Home / Health / Parents Fight for Life-Saving Drug for Baby
Parents Fight for Life-Saving Drug for Baby
4 Feb
Summary
- 14-month-old Melody needs £20,000-a-month cancer drug.
- Drug is a menin inhibitor approved in the US, not UK.
- Family has raised nearly £50,000 for the treatment.
A 14-month-old girl, Melody Hewitt-Aggett, has been diagnosed with an aggressive form of blood cancer. Her parents have been informed that a groundbreaking drug, Revuforj, could save her life, but it comes with a substantial cost.
The drug, a menin inhibitor, is approved in the US but not yet in the UK. It is estimated to cost the family approximately £500,000 over two years, with monthly expenses reaching £20,000. Melody's consultant has requested approval for its import, potentially making her the first UK patient to receive this treatment.
Melody's parents, Rachel-Elizabeth and Kevin, have already raised nearly £50,000 towards the goal. They discovered the drug through their own research, as Melody's condition has not responded to conventional treatments like chemotherapy and a bone marrow transplant. Doctors have indicated that Melody needs the treatment as soon as possible to survive.
The family is determined to fight for their daughter's chance at survival, refusing to give up hope. Melody's resilience and smile throughout her difficult journey have been a source of strength for her parents as they navigate this challenging situation.
